Seeing Is Believing
Currently out of the existing stock ratings of James Gordon, 23 are a BUY (36.51%), 38 are a HOLD (60.32%), 2 are a SELL (3.17%).
Analyst James Gordon, currently employed at BAML, carries an average stock price target met ratio of 58.72% that have a potential upside of 29.06% achieved within 209 days.
James Gordon’s has documented 125 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 04-Nov-2024.
Analyst best performing recommendations are on GRFS (GRIFOLS SA ADR).
The best stock recommendation documented was for GRFS (GRIFOLS SA ADR) at 1/3/2023. The price target of $9.09 was fulfilled within 1 day with a profit of $0.35 (4%) receiving and performance score of 40.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$103
$18.83 (22.37%)
$107
6 days ago
(14-Nov-2024)
14/21 (66.67%)
$17.48 (20.44%)
334
Buy
$106
$21.83 (25.94%)
$104
1 months 6 days ago
(14-Oct-2024)
9/11 (81.82%)
$8.8 (9.05%)
91
Buy
$110
$25.83 (30.69%)
$104
2 months 29 days ago
(22-Aug-2024)
7/9 (77.78%)
$14.67 (15.39%)
282
Buy
$105
$20.83 (24.75%)
$100
6 months 5 days ago
(15-May-2024)
11/12 (91.67%)
$15.03 (16.71%)
311
Buy
$100
$15.83 (18.81%)
$90
8 months 16 days ago
(04-Mar-2024)
6/6 (100%)
$13.26 (15.29%)
297
Which stock is James Gordon is most bullish on?
What Year was the first public recommendation made by James Gordon?